-
Ab183423-5mgForalumab (anti-CD3E) is a monoclonal antibody directed against cluster of differentiation 3 (CD3) epsilon with immunomodulatory activity.Purity≥95%(SDS-PAGE&:SEC)Endotoxin Level <: 0.01EU/μg.
-
Ab183423-1mgForalumab (anti-CD3E) is a monoclonal antibody directed against cluster of differentiation 3 (CD3) epsilon with immunomodulatory activity.Purity≥95%(SDS-PAGE&:SEC)Endotoxin Level <: 0.01EU/μg.
-
Ab183423-10mgForalumab (anti-CD3E) is a monoclonal antibody directed against cluster of differentiation 3 (CD3) epsilon with immunomodulatory activity.Purity≥95%(SDS-PAGE&:SEC)Endotoxin Level <: 0.01EU/μg.
-
Ab183423-100μgForalumab (anti-CD3E) is a monoclonal antibody directed against cluster of differentiation 3 (CD3) epsilon with immunomodulatory activity.Purity≥95%(SDS-PAGE&:SEC)Endotoxin Level <: 0.01EU/μg.
-
Ab183339-5mgVorsetuzumab mafodotin (anti-CD70) is an antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the extracellular domain of the human CD70 molecule, and a cytotoxic tubulin polymerization inhibitor. It is used in
-
Ab183339-1mgVorsetuzumab mafodotin (anti-CD70) is an antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the extracellular domain of the human CD70 molecule, and a cytotoxic tubulin polymerization inhibitor. It is used in
-
Ab183339-10mgVorsetuzumab mafodotin (anti-CD70) is an antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the extracellular domain of the human CD70 molecule, and a cytotoxic tubulin polymerization inhibitor. It is used in
-
Ab183339-100μgVorsetuzumab mafodotin (anti-CD70) is an antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the extracellular domain of the human CD70 molecule, and a cytotoxic tubulin polymerization inhibitor. It is used in
-
Ab183323-5mgPinatuzumab vedotin (anti-CD22), is an antibody-drug conjugate (ADC) composed of CD22 (Sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14) antibody and cytotoxic agent monomethyl auristatin E
-
Ab183323-1mgPinatuzumab vedotin (anti-CD22), is an antibody-drug conjugate (ADC) composed of CD22 (Sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14) antibody and cytotoxic agent monomethyl auristatin E
-
Ab183323-10mgPinatuzumab vedotin (anti-CD22), is an antibody-drug conjugate (ADC) composed of CD22 (Sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14) antibody and cytotoxic agent monomethyl auristatin E
-
Ab183323-100μgPinatuzumab vedotin (anti-CD22), is an antibody-drug conjugate (ADC) composed of CD22 (Sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14) antibody and cytotoxic agent monomethyl auristatin E